Natixis Advisors, L.P. Bio Techne Corp Transaction History

Natixis Advisors, L.P.

$63 Billion
Q2 2025

A detailed history of Natixis Advisors, L.P. transactions in Bio Techne Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 98,331 shares of TECH stock, worth $5.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

98,331

Previous 124,917 21.28%

Holding current value

$5.82 Million

Previous $7.32 Million 30.93%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$46.66 - $58.38 $1.24 Million - $1.55 Million	-26,586 Reduced 21.28%	98,331 $5.06 Million
Q1 2025 May 08, 2025	SELL	$58.47 - $78.75 $2.62 Million - $3.53 Million	-44,764 Reduced 26.38%	124,917 $7.32 Million
Q4 2024 Feb 10, 2025	BUY	$66.37 - $78.17 $771,551 - $908,726	11,625 Added 7.35%	169,681 $12.2 Million
Q3 2024 Nov 06, 2024	BUY	$70.96 - $82.35 $1.16 Million - $1.34 Million	16,328 Added 11.52%	158,056 $12.6 Million
Q2 2024 Aug 01, 2024	SELL	$62.12 - $84.15 $6.91 Million - $9.36 Million	-111,240 Reduced 43.97%	141,728 $10.2 Million
Q1 2024 Apr 25, 2024	SELL	$65.98 - $77.09 $2.06 Million - $2.41 Million	-31,224 Reduced 10.99%	252,968 $17.8 Million
Q4 2023 Feb 06, 2024	BUY	$52.83 - $78.22 $3.31 Million - $4.9 Million	62,632 Added 28.27%	284,192 $21.9 Million
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $2.88 Million - $3.82 Million	-42,723 Reduced 16.17%	221,560 $15.1 Million
Q2 2023 Aug 15, 2023	BUY	$73.76 - $85.98 $2.21 Million - $2.58 Million	30,008 Added 12.81%	264,283 $21.6 Million
Q1 2023 May 11, 2023	BUY	$71.62 - $86.62 $152,478 - $184,413	2,129 Added 0.92%	234,275 $17.4 Million
Q4 2022 Jan 27, 2023	BUY	$80.67 - $352.29 $15.4 Million - $67.4 Million	191,238 Added 467.48%	232,146 $19.2 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $389,905 - $540,753	1,380 Added 3.49%	40,908 $11.6 Million
Q2 2022 Aug 12, 2022	BUY	$322.67 - $449.65 $315,571 - $439,757	978 Added 2.54%	39,528 $13.7 Million
Q1 2022 May 12, 2022	BUY	$353.85 - $487.79 $3.69 Million - $5.09 Million	10,442 Added 37.15%	38,550 $16.7 Million
Q4 2021 Feb 08, 2022	BUY	$456.15 - $525.06 $38,316 - $44,105	84 Added 0.3%	28,108 $14.5 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $302,511 - $366,438	680 Added 2.49%	28,024 $13.6 Million
Q2 2021 Aug 12, 2021	SELL	$387.35 - $450.26 $216,916 - $252,145	-560 Reduced 2.01%	27,344 $12.3 Million
Q1 2021 May 05, 2021	SELL	$314.62 - $411.0 $152,905 - $199,746	-486 Reduced 1.71%	27,904 $10.7 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $1.31 Million - $1.7 Million	5,293 Added 22.92%	28,390 $9.02 Million
Q3 2020 Nov 12, 2020	SELL	$232.22 - $282.96 $444,469 - $541,585	-1,914 Reduced 7.65%	23,097 $5.72 Million
Q2 2020 Aug 11, 2020	BUY	$185.43 - $279.56 $2.23 Million - $3.37 Million	12,049 Added 92.96%	25,011 $6.61 Million
Q1 2020 Apr 27, 2020	SELL	$161.17 - $221.51 $17,245 - $23,701	-107 Reduced 0.82%	12,962 $2.46 Million
Q4 2019 Feb 10, 2020	BUY	$189.68 - $222.09 $546,278 - $639,619	2,880 Added 28.27%	13,069 $2.87 Million
Q3 2019 Nov 12, 2019	BUY	$183.56 - $216.72 $1.87 Million - $2.21 Million	10,189 New	10,189 $1.99 Million

Others Institutions Holding TECH

# of Institutions

614

Shares Held

162M

Call Options Held

225K

Put Options Held

80.8K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.32B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Bio Techne Corp Transaction History